Series A · AI & Machine Learning · London, United Kingdom · Founded 2021 · 11–50 employees
Apoha is a deep tech and AI startup pioneering the field of Liquid State Intelligence by digitizing molecular behavior under real-world stresses. The company utilizes proprietary hardware, including its VIBE platform, to apply physical forces to liquid-suspended samples and generate behavioral data to train AI models. The technology targets pharmaceutical antibody drug discovery, food and beverage design, and advanced materials. Apoha has established a notable commercial partnership with Boehringer Ingelheim to identify high-risk candidate liabilities during drug discovery. The company emerged from stealth in June 2026 with a substantial Series A funding round led by Singular.
No open roles listed right now.